Menu
Log in

35th Annual Fall Symposium Lecture Series (Virtual) Session 1, COVID-19 Therapeutics

Event
35th Annual Fall Symposium Lecture Series (Virtual) Session 1, COVID-19 Therapeutics
 
October 01, 2020 4:00 PM - 6:00 PM
 
Location: Virtual Symposium

Registered attendees (54)

Date Name
September 16, 2020 Fitzgibbons, Michael W.
September 14, 2020 Anonymous user
September 14, 2020 Deck, Daniel
September 12, 2020
September 12, 2020 Anonymous user
September 11, 2020 Bock, Bonnie V.
September 10, 2020 Lalla-Reddy, Sujata - plus 1 guest
September 10, 2020
September 10, 2020
September 10, 2020 Anonymous user
ACCREDITATION--
The Infectious Disease Association of California (IDAC) is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians. IDAC takes responsibility for the content, quality, and scientific integrity of this CME activity.

PHYSICIANS: IDAC designates this educational activity for a maximum of 6.0* AMA PRA Category 1 Credit(s)™ and American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program points for medical knowledge. Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.

PHARMACISTS: The California Board of Pharmacy accepts coursework which meets the standard of relevance to pharmacy practice and has been approved for AMA PRA Category 1 Credit™. A maximum of 6.0* C.E.U.s may be reported.

NURSES: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credits™ issued by organizations accredited by the ACCME. For the purpose of relicensure, the California Board of Registered Nursing accepts AMA PRA Category 1. Credits™. A maximum of 6.0* C.E.U.s may be reported. .



Powered by Wild Apricot Membership Software